GR76847B - - Google Patents

Info

Publication number
GR76847B
GR76847B GR68485A GR820168485A GR76847B GR 76847 B GR76847 B GR 76847B GR 68485 A GR68485 A GR 68485A GR 820168485 A GR820168485 A GR 820168485A GR 76847 B GR76847 B GR 76847B
Authority
GR
Greece
Application number
GR68485A
Other languages
Greek (el)
Inventor
William Lesley Matier
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of GR76847B publication Critical patent/GR76847B/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR68485A 1981-06-23 1982-06-18 GR76847B (US06236872-20010522-M00003.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/276,658 US4454154A (en) 1981-06-23 1981-06-23 Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents

Publications (1)

Publication Number Publication Date
GR76847B true GR76847B (US06236872-20010522-M00003.png) 1984-09-04

Family

ID=23057573

Family Applications (1)

Application Number Title Priority Date Filing Date
GR68485A GR76847B (US06236872-20010522-M00003.png) 1981-06-23 1982-06-18

Country Status (17)

Country Link
US (1) US4454154A (US06236872-20010522-M00003.png)
EP (1) EP0082873B1 (US06236872-20010522-M00003.png)
JP (1) JPH0653663B2 (US06236872-20010522-M00003.png)
AU (1) AU565752B2 (US06236872-20010522-M00003.png)
CA (1) CA1188224A (US06236872-20010522-M00003.png)
CH (1) CH654205A5 (US06236872-20010522-M00003.png)
ES (1) ES8401928A1 (US06236872-20010522-M00003.png)
GB (1) GB2111387B (US06236872-20010522-M00003.png)
GR (1) GR76847B (US06236872-20010522-M00003.png)
IL (1) IL66070A (US06236872-20010522-M00003.png)
IT (1) IT1156058B (US06236872-20010522-M00003.png)
NL (1) NL8220252A (US06236872-20010522-M00003.png)
NZ (1) NZ200972A (US06236872-20010522-M00003.png)
PH (1) PH18970A (US06236872-20010522-M00003.png)
SE (1) SE462075B (US06236872-20010522-M00003.png)
WO (1) WO1983000014A1 (US06236872-20010522-M00003.png)
ZA (1) ZA824340B (US06236872-20010522-M00003.png)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334601A (en) * 1984-03-14 1994-08-02 Bodor Nicholas S Soft β-adrenergic blocking agents
US5202347A (en) * 1984-03-14 1993-04-13 Bodor Nicholas S Soft β-adrenergic blocking agents
US5135926A (en) * 1984-03-14 1992-08-04 Bodor Nicholas S Soft β-adrenergic blocking agents
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
EP0286903B2 (en) * 1987-04-03 2000-03-29 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
CA1334168C (en) * 1988-04-26 1995-01-31 Louis M. De Santis Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers
US4857552A (en) * 1988-06-08 1989-08-15 E. I. Du Pont De Nemours And Co. Stable pharmaceutical composition
US5536749A (en) * 1994-10-13 1996-07-16 Sl Pharmaceuticals, Inc. Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents
US6197817B1 (en) 1999-01-22 2001-03-06 Selectus Pharmaceuticals, Inc. Phenylpropionic acids and esters: compounds and methods for inducing beta-blockade for the treatment of cardiac disorders
AU2005247480A1 (en) * 2004-05-25 2005-12-08 Qlt Inc. Oculoselective drugs and prodrugs

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868460A (en) * 1967-02-06 1975-02-25 Boehringer Sohn Ingelheim Therapeutic compositions and method
DE1593762A1 (de) * 1967-02-06 1972-06-08 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
US3740444A (en) * 1968-01-25 1973-06-19 Boehringer Sohn Ingelheim Therapeutic compositions and method
GB1285038A (en) * 1969-02-21 1972-08-09 Ici Ltd Alkanolamine derivatives
DE1922003C3 (de) * 1969-04-30 1979-10-11 Boehringer Mannheim Gmbh, 6800 Mannheim N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz
DE2048838A1 (de) * 1970-10-05 1972-04-06 C H Boehnnger Sohn, 6507 Ingel heim Neue 1 Phenoxy 2 hydroxy 3 hydroxyal kylaminopropane und Verfahren zu ihrer Her stellung
FR2132570B1 (US06236872-20010522-M00003.png) * 1971-04-09 1974-08-02 Lipha
JPS4875539A (US06236872-20010522-M00003.png) * 1972-01-12 1973-10-11
JPS49247A (US06236872-20010522-M00003.png) * 1972-04-17 1974-01-05
US3839584A (en) * 1972-08-31 1974-10-01 Interx Research Corp Pharmaceutical compositions containing a novel ester of ((methylamino)methyl)benzyl alcohol and methods of using same
AT330150B (de) * 1973-02-28 1976-06-10 Boehringer Sohn Ingelheim Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen
US3825583A (en) * 1973-04-26 1974-07-23 Interx Research Corp Ester of 3-hydroxy-alpha-((methylamino)methyl)benzyl alcohol
US4195085A (en) * 1975-09-26 1980-03-25 Merck & Co., Inc. Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
US4191765A (en) * 1976-05-25 1980-03-04 Hoechst Aktiengesellschaft 1-Aryloxy-2-hydroxy-3-aminopropanes
US4080471A (en) * 1976-06-25 1978-03-21 Aktiebolaget Hassle Use of substituted isopropylaminopropanols for inducing inotropic effects of the human heart
DE2752659A1 (de) * 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
US4127674A (en) * 1977-03-21 1978-11-28 Allergan Pharmaceuticals, Inc. Method of treatment for glaucoma
DE2962112D1 (en) * 1978-02-08 1982-03-25 Ici Plc Alkanolamine derivatives, process for their preparation and pharmaceutical compositions containing them
SE8004087L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...
SE8004088L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya substituerade 3-fenoxi-l-alkoxikarbonylalkylamino-propanol-2-er med beta-receptorblockerande egenskaper samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma och metod att ...
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders

Also Published As

Publication number Publication date
SE8300913D0 (sv) 1983-02-18
IL66070A (en) 1987-03-31
CA1188224A (en) 1985-06-04
NZ200972A (en) 1986-10-08
EP0082873A4 (en) 1983-11-11
WO1983000014A1 (en) 1983-01-06
IT8267796A0 (it) 1982-06-22
AU8737482A (en) 1983-01-18
US4454154A (en) 1984-06-12
ZA824340B (en) 1983-04-27
GB8303061D0 (en) 1983-03-09
GB2111387A (en) 1983-07-06
EP0082873A1 (en) 1983-07-06
GB2111387B (en) 1986-02-05
NL8220252A (nl) 1983-05-02
IT1156058B (it) 1987-01-28
JPS58500996A (ja) 1983-06-23
AU565752B2 (en) 1987-09-24
ES513387A0 (es) 1984-01-01
SE462075B (sv) 1990-05-07
EP0082873B1 (en) 1988-12-07
IL66070A0 (en) 1982-09-30
PH18970A (en) 1985-11-26
JPH0653663B2 (ja) 1994-07-20
SE8300913L (en) 1983-02-18
ES8401928A1 (es) 1984-01-01
CH654205A5 (de) 1986-02-14

Similar Documents

Publication Publication Date Title
FR2498240B1 (US06236872-20010522-M00003.png)
DE8230398U1 (US06236872-20010522-M00003.png)
FR2497504B1 (US06236872-20010522-M00003.png)
FR2498340B1 (US06236872-20010522-M00003.png)
DE3229452C2 (US06236872-20010522-M00003.png)
DE3148957C2 (US06236872-20010522-M00003.png)
DE3226637C2 (US06236872-20010522-M00003.png)
DE3205477C2 (US06236872-20010522-M00003.png)
DE3101369C2 (US06236872-20010522-M00003.png)
DE3221545C2 (US06236872-20010522-M00003.png)
GR76847B (US06236872-20010522-M00003.png)
FR2497989B1 (US06236872-20010522-M00003.png)
FR2508703B1 (US06236872-20010522-M00003.png)
FR2497459B1 (US06236872-20010522-M00003.png)
FR2497741B3 (US06236872-20010522-M00003.png)
DE3150414C2 (US06236872-20010522-M00003.png)
DE3145804C2 (US06236872-20010522-M00003.png)
FR2491736B3 (US06236872-20010522-M00003.png)
DE3109605C2 (US06236872-20010522-M00003.png)
DE3205031C2 (US06236872-20010522-M00003.png)
FR2497507B3 (US06236872-20010522-M00003.png)
DE3225622C2 (US06236872-20010522-M00003.png)
FR2498387B1 (US06236872-20010522-M00003.png)
JPS614886B2 (US06236872-20010522-M00003.png)
FR2497752B3 (US06236872-20010522-M00003.png)